RESUMO
Background: The Enterics for Global Health (EFGH) Peru site will enroll subjects in a periurban area of the low Amazon rainforest. The political department of Loreto lags behind most of Peru in access to improved sources of water and sanitation, per capita income, children born <2.5â kg, and infant and child mortality. Chronic undernutrition as manifested by linear growth shortfalls is common, but wasting and acute malnutrition are not. Methods: The recruitment of children seeking care for acute diarrheal disease takes place at a geographic cluster of government-based primary care centers in an area where most residents are beneficiaries of free primary healthcare. Results: Rates of diarrheal disease, dysentery, and Shigella are known to be high in the region, with some of the highest rates of disease documented in the literature and little evidence in improvement over the last 2 decades. This study will update estimates of shigellosis by measuring the prevalence of Shigella by polymerase chain reaction and culture in children seeking care and deriving population-based estimates by measuring healthcare seeking at the community level. Conclusions: Immunization has been offered universally against rotavirus in the region since 2009, and in a context where adequate water and sanitation are unlikely to obtain high standards in the near future, control of principal enteropathogens through immunization may be the most feasible way to decrease the high burden of disease in the area in the near future.
RESUMO
OBJECTIVES: Antimicrobial resistant (AMR) Campylobacter is a global health threat; however, there is limited information on genomic determinants of resistance in low- and middle-income countries. We evaluated genomic determinants of AMR using a collection of whole genome sequenced Campylobacter jejuni and C. coli isolates from Iquitos, Peru. METHODS: Campylobacter isolates from two paediatric cohort studies enriched with isolates that demonstrated resistance to ciprofloxacin and azithromycin were sequenced and mined for AMR determinants. RESULTS: The gyrA mutation leading to the Thr86Ile amino acid change was the only gyrA mutation associated with fluoroquinolone resistance identified. The A2075G mutation in 23S rRNA was present, but three other 23S rRNA mutations previously associated with macrolide resistance were not identified. A resistant-enhancing variant of the cmeABC efflux pump genotype (RE-cmeABC) was identified in 36.1% (35/97) of C. jejuni genomes and 17.9% (12/67) of C. coli genomes. Mutations identified in the CmeR-binding site, an inverted repeat sequence in the cmeABC promoter region that increases expression of the operon, were identified in 24/97 C. jejuni and 14/67 C. coli genomes. The presence of these variants, in addition to RE-cmeABC, was noted in 18 of the 24 C. jejuni and 9 of the 14 C. coli genomes. CONCLUSIONS: Both RE-cmeABC and mutations in the CmeR-binding site were strongly associated with the MDR phenotype in C. jejuni and C. coli. This is the first report of RE-cmeABC in Peru and suggests it is a major driver of resistance to the principal therapies used to treat human campylobacteriosis in this setting.
Assuntos
Antibacterianos , Campylobacter , Humanos , Criança , Antibacterianos/farmacologia , Peru , RNA Ribossômico 23S/genética , Farmacorresistência Bacteriana/genética , Macrolídeos , Campylobacter/genética , GenômicaRESUMO
In countries where soil-transmitted helminth (STH) infections are endemic, deworming programs are recommended to reduce morbidity; however, increasing levels of resistance to benzimidazoles are of concern. In an observational study in Peru, we studied the clinical efficacy of 400 mg of albendazole 20 days after treatment among children aged 2-11 years. Of 426 participants who provided samples, 52.3% were infected with a STH, 144 (33.8%) were positive for Ascaris (41.8% light, 50.8% moderate, and 7.4% heavy infections), 147 (34.5%) were positive for Trichuris (75.2% light, 22.5% moderate, and 2.3% heavy infections), and 1.1% were positive for hookworm species (100% light infections). Additional stool samples were examined at 20, 90, and 130 days after the initial treatment. At 20 days post-administration of albendazole, the cure rate (CR) of Ascaris infection was 80.1% (95% CI: 73.5-86.7), and the egg reduction rate (ERR) was 70.8% (95% CI: 57.8-88.7); the CR for Trichuris infection was 27.1% (95% CI: 20.0-34.3), and the ERR was 29.8% (95% CI: -1.40 to 57.5). Among participants with persistent or recurrent infections with Trichuris, the combined therapy of albendazole (400 mg) and ivermectin at 600 µg/dose increased overall CR for Trichuris infection to 75.2% (95% CI: 67.3-83.2%) with an ERR of 84.2% (95% CI: 61.3-93.8%). Albendazole administration alone for the control of STH was associated with high rates of treatment failure, especially for Trichuris. Combined single doses of albendazole and ivermectin was observed to have improved efficacy.
Assuntos
Albendazol , Anti-Helmínticos , Helmintíase , Ivermectina , Solo , Humanos , Albendazol/uso terapêutico , Albendazol/administração & dosagem , Peru/epidemiologia , Pré-Escolar , Criança , Ivermectina/uso terapêutico , Ivermectina/administração & dosagem , Masculino , Feminino , Solo/parasitologia , Helmintíase/tratamento farmacológico , Helmintíase/epidemiologia , Anti-Helmínticos/uso terapêutico , Anti-Helmínticos/administração & dosagem , Fezes/parasitologia , Quimioterapia Combinada , Animais , Resultado do Tratamento , Tricuríase/tratamento farmacológico , Tricuríase/epidemiologia , Ascaríase/tratamento farmacológico , Ascaríase/epidemiologia , Trichuris/efeitos dos fármacosRESUMO
Se presenta el caso de un neonato de sexo femenino, a término, producto de madre fallecida al séptimo día de su puerperio, por falla multiorgánica debido a dengue grave confirmado por detección de antígeno NS1 e IgM. La recién nacida (RN) no tuvo complicaciones, pero a partir del cuarto día de vida desarrolló fiebre, ictericia, manifestaciones de extravasación de plasma, hepatomegalia, ascitis, plaquetopenia y otros signos de síndrome de respuesta inflamatoria sistémica. Su evolución final fue favorable con tratamiento instaurado. Se demuestra con PCR en tiempo real, la presencia del virus dengue serotipo 2 en sangre de la RN, confirmándose el primer caso de dengue neonatal reportado en el Perú.
We present the case of a full-term female newborn, whose mother died seven days postpartum from multi-organ failure due to severe dengue confirmed by NS1 antigen detection and positive IgM. The newborn did not have any complication, but at the fourth day of life she developed fever, jaundice, signs of plasma leakage, thrombocytopenia, hepatomegaly, ascitis, and others signs of systemic inflammation response syndrome. She fully recovered with supportive treatment. The RT-PCR test of a peripheral blood sample revealed a positive result for the dengue virus serotype 2, confirming the first case of neonatal dengue reported in Peru.
Assuntos
Feminino , Humanos , Recém-Nascido , Dengue , Dengue/diagnóstico , PeruRESUMO
El presente estudio nos reporta los resultados obtenidos sobre pruebas de toxicidad aguda de la especie vegetal Uncaria guianensis "Uña de gato" con ratas albinas cepa Holtzmann de ambos sexos, realizadas en el laboratorio de Farmacología del Instituto de Medicina Tradicional del Instituto Peruano de Seguridad Social. En el presente estudio se utilizó ratas albinas de 80 días de edad, de ambos sexos, que fueron divididas para 02 tipos de experimentos; el primer experimento (pruebas de toxicidad agua vía intraperitoneal), tuvo 03 grupos de animales, conformados por 05 animales cada grupo y un grupo control de 02 animales, fueron inoculados con la dosis 8, 6 y 4 gr/kg. de peso; el segundo experimento (Prueba de toxicidad aguda vía oral), tuvo tres grupos de animales, conformados por 05 animales cada grupo y un grupo control de 02 animales, fueron inoculados con la dosis 10, 8 y 6 gr/kg. de peso, inoculándose para ambos experimentos agua destilada en los grupos controles y las evaluaciones post inoculaciones en ambos grupos, fueron durante las 24, 48 y 72 horas. Durante las observaciones post inoculaciones, vía intraperitoneal, se observan muertes del 100 por ciento, en las dosis 8 y 6 gr/kg. y del 60 por ciento en las dosis 4 gr/kg. de peso, dentro de las 72 horas, mientras que por vía oral, no se observan muertes en las dosis 10, 8 y 6 gr/kg. dentro de las 72 horas.
Assuntos
Animais , Ratos , Testes de Toxicidade , Medicina Tradicional , Plantas Medicinais , Testes de ToxicidadeRESUMO
Estudia 101 lactantes nacidos en el Hospital de San Juan de Marcona (depatamento de Ica-Perú), los que se dividieron en dos grupos: el primero conformado por 50 lactantes alimentados con leche materna y el segundo por 51 alimentados con leche evaporada. Ambos grupos recibieron únicamente leche hasta los 3 meses, y luego la complementaron con alimentos no lacteo. Los dos grupos de lactantes fueron considerados sanos al nacimiento y en los controles a los 3 y 6 meses. En las fechas de control, se les practicó un minucioso examen clínico, que incluyó el pesaje y tallado. Además, se complementó con perfil hematológico que implica determianciones de hemoglobina, hematocrito, hierro sérico, transferrina, saturación de transferrina, volumen globular medio, hemoglobina glovular media y concentración de hemoglobinaa globular media. El control comprendió examen clínico y hematológico. El grupo de lactantes a biberón mostró a los 3 y 6 meses, valores promedios indicativos de deficiencia de hierro: con una media de hierro sérico inferior de 50m.c.g/dl, saturación de transferrina inferior a 16% y tendencia la micrositosis, con manifestaciones de anemia, con hemoglobina promedio inferior a 11g/dl. Los lactantes a pecho mostraron valores promedio de hierro de hemoglobina promedio superior a 11 g/dl. y normalidad en la morfología. El estudio permite afirmar que los lactantes menores de 6 meses que son alimentados con leche evaporada, tienen un rasgo mayor de desarrollar deficiência de hierro y anemia microcítica que los pacientes alimentados con leche materna
Assuntos
Lactente , Humanos , Masculino , Feminino , Anemia Hipocrômica/epidemiologia , Lactação , PeruRESUMO
Estudio sobre las condiciones antiinflamatorias de la planta del achiote cuyo nombre científico es el de Bixa Orellana
Assuntos
Anti-Inflamatórios/farmacologia , Bixa orellana/farmacologia , Plantas Medicinais , PeruRESUMO
Contiene: La etnobotánica en la amazonía; Comunidades indígenas; Grupos étnicos y plantas medicinales; Curanderos y chamanes en Iquitos; Síndromes culturales; Hierberos y herboristerías en Iquitos; Catálogo de plantas IMET-EsSALUD; Conservación de la biodiversidad; Indice de especies medicinales por nombres vulgares; Indice de especies medicinales por nombre científico; Bibliografía
Assuntos
Plantas Medicinais , PeruRESUMO
Estudio realizado en las plantas de: achiote, ajo sacha, chancapiedra, hierba luisa, llanten, malva, mango, manzanilla, matico, mucura, ojo de pollo y uña de gato